Charite University, Berlin, Germany
charite.deLive pipeline data from ClinicalTrials.gov, refreshed daily.
Total trials
848
Active
111
Phase 3
57
Total enrollment
3,733,028
Pipeline matrix
Showing 18 of 18 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Tofacitinib 5 MG | — | — | — | — | — | 1 | |
| Inotuzumab ozogamicin | — | — | — | — | — | 1 | |
| Blinatumomab | — | — | — | — | — | 1 | |
| FOLFIRI+cetuximab | — | — | — | — | — | 1 | |
| Rituximab | — | — | — | — | 4 | ||
| Bortezomib | — | — | — | — | — | 2 | |
| Vericiguat Oral | — | — | — | — | — | 1 | |
| KYV101 | — | — | — | — | — | 1 | |
| Lumasiran | — | — | — | — | — | 1 | |
| 0.9% Sodium Chloride | — | — | — | — | — | 1 | |
| Optimal Medical Therapy | — | — | — | — | — | 1 | |
| Treatment with cystic fibrosis transmembrane regulator (CFTR) modualtors Ivacaftor, Lumacaftor-Ivacaftor, Tezacaftor-Ivacaftor, Elexacaftor-Tezacaftor-Ivacaftor, Vanzacaftor-Tezacaftor-Deutivacaftor | — | — | — | — | — | 1 | |
| L-dopa/Carbidopa | — | — | — | — | — | 1 | |
| fMRI imaging | — | — | — | — | — | 1 | |
| sMRI | — | — | — | — | — | 1 | |
| off-label compassionate drug use | — | — | — | — | — | 1 | |
| Dronabinol | — | — | — | — | — | 1 | |
| Estradiol Valerate | — | — | — | — | — | 1 |
Next readouts
- 2023-12-31
- 2024-12-31
- 2025-01-30
- 2025-03
- 2026-04-01
- 2026-07
- 2027-03-31
- 2027-06
- 2027-11-30
- 2027-12-31
Top conditions
- Stroke24
- Healthy18
- Multiple Sclerosis12
- Delirium12
- Heart Failure11
- Depression10
- Ankylosing Spondylitis10
- Critical Illness10
Frequently asked questions about Charite University, Berlin, Germany
- How many clinical trials does Charite University, Berlin, Germany have on ClinicalTrials.gov?
- Charite University, Berlin, Germany is listed as the lead sponsor on 848 clinical trials in ClinicalTrials.gov, 111 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Charite University, Berlin, Germany's trials are in Phase 3?
- 57 of Charite University, Berlin, Germany's trials are in Phase 3, spread across 18 active drug programs.
- What therapeutic areas does Charite University, Berlin, Germany focus on?
- Charite University, Berlin, Germany's most-studied conditions on ClinicalTrials.gov are Stroke, Healthy, Multiple Sclerosis, Delirium, Heart Failure.
- When are Charite University, Berlin, Germany's next clinical trial readouts?
- Charite University, Berlin, Germany has 10 upcoming primary-completion readouts tracked here; the soonest is “The Effect of Dronabinol on the Acquisition and Consolidation of Trauma-Associated Memories”, expected around 2023-12-31.